Epidemiological Landscape of Cervical Cancer in Latin America

Epidemiological Landscape of Cervical Cancer in Latin America .

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04947605

Acronym

EVITA LATAM

Enrollment

524

Registered

2021-07-01

Start date

2021-11-04

Completion date

2027-12-01

Last updated

2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Cervical Neoplasms

Keywords

Cervical Neoplasms

Brief summary

A portrait of clinical and epidemiological aspects of cervical cancer in Latin America is required to understand the high frequency of cervical cancer despite the existence of effective preventive tools. A better understanding of the current situation of this scenario will provide a valuable groundwork for the development of national and cooperative programs to improve cervical cancer prevention and treatment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Women \> 18 years. * Histologically proven cervical carcinoma * Diagnosis of carcinoma of the cervix since January 2018 or newly diagnosis or recurrent disease during the period of study recruitment. * Any histology of cervical cancer at time of diagnosis. * FIGO stage IB2-IVA * Have available and adequate medical records for data collection * Accept to participate in the project and sign the informed consent (if applicable)

Exclusion criteria

* FIGO stage I and IB1 * Non-invasive cervical cancer * Synchronous tumor or second primary tumor in the last five years (exception for thyroid cancer or skin cancer non melanoma)

Design outcomes

Primary

Measure	Time frame	Description
- Summarize the histologic subtype	January of 2028	Summarize the histologic subtype, assessed by the anatomopathological assay of the tumor sample and the stage at diagnosis, assessed by FIGO stage (International Federation of Gynecology and Obstetrics (FIGO) staging of cancer of the cervix uteri - 2018), using gynecological exam. Image studies and TNM stage (AJCC 8th edition) will also be used to assess stage at diagnosis when available.

Countries

Argentina, Brazil, Dominican Republic, Peru

Contacts

PRINCIPAL_INVESTIGATORGraziela Zibetti Dal Molin, MD

Latin American Cooperative Oncology Group

Outcome results